This company listing is no longer active
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Zenosense, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0009 |
52 Week High | US$0.02 |
52 Week Low | US$0.0003 |
Beta | -115.63 |
1 Month Change | -10.00% |
3 Month Change | 50.00% |
1 Year Change | 50.00% |
3 Year Change | -94.38% |
5 Year Change | -99.72% |
Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
ZENO | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | -0.2% | 1.3% |
1Y | 50.0% | 10.6% | 29.8% |
Return vs Industry: ZENO exceeded the US Medical Equipment industry which returned 6.1% over the past year.
Return vs Market: ZENO exceeded the US Market which returned 15.1% over the past year.
Price Volatility
ZENO volatility | |
---|---|
ZENO Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ZENO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ZENO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | n/a | Zhongjian Hu | https://www.zenosense.com |
Zenosense, Inc. does not have significant operations. Previously, the company operated as a healthcare technology company. It intends to explore and identify business opportunities seeking to acquire a business in a reverse merger, asset purchase, or similar transaction.
Zenosense, Inc. Fundamentals Summary
ZENO fundamental statistics | |
---|---|
Market cap | US$56.64k |
Earnings (TTM) | -US$302.46k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs ZENO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZENO income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$302.46k |
Earnings | -US$302.46k |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0048 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -30.1% |
How did ZENO perform over the long term?
See historical performance and comparison